it is just unbelievable the FDA has time to watch videos

New Post Public Reply Private Reply Replies (2) Message Board
gestalt2 Buddyboy20 #118825
780
it is just unbelievable the FDA has time to watch videos and complain in detail about this crap but can't lift a finger to actually look at what this drug does. They should be helping get trials filled, protocals approved and putting there top people in getting this drug on the market. How many more need to die FDA?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zhihu Inc.'s Share Units Grant: Incentives and Performance Insights

Updated Category News Views 54

Zhihu Inc. Issues Restricted Share Units to Enhance Employee Incentives Zhihu Inc. (NYSE:ZH), a prominent online content community, recently disclosed an important development concerning its employee incentive programs. The company has issued restricted share units, aligning with its 2022 Share Incentive Plan, as documented in a Form 6-K filed with the Securities and...

Continue Reading
How to Make the Cash in Your Investment Portfolio Work Harder

Updated Category Investing Views 114

Ask most investors where their money sits and they will describe their equity positions in detail. Ask about the cash and the answer gets vague fast. That cash is usually the least examined line on the whole balance sheet. It is also, for a lot of people, a meaningful share of net worth sitting somewhere that was chosen years ago and never revisited. Cash is not the...

Continue Reading
Novo Nordisk's amycretin Moves to Phase 3 for Weight Management

Updated Category News Views 546

Advancements in Obesity Treatment by Novo Nordisk In the quest for effective obesity treatments, Novo Nordisk has made significant strides with their investigational drug, amycretin. This novel therapy aims to assist individuals struggling with obesity by targeting appetite regulation. Recent results from early-phase clinical trials have been published, showcasing...

Continue Reading
Shell's Challenge in Finalizing the German Refinery Deal

Updated Category News Views 133

Shell Faces Challenges in Selling the Schwedt Refinery Shell is currently encountering significant delays in its efforts to sell a stake in the Schwedt refinery. A number of pending lawsuits from third parties are largely responsible for this situation, placing a long-anticipated divestment on hold. The Schwedt refinery is vital for fuel supply, and this contentious sale...

Continue Reading
Stock Images Market Poised for Growth with Increasing Demand

Updated Category News Views 319

Exploring the Growth of the Stock Images Market The stock images market is experiencing a promising expansion, with estimates that it will grow by USD 1.28 billion between 2025 and 2029. This growth is driven by the increasing need for high-quality imagery for various applications, fostering a continually evolving market landscape. Market Segmentation Insights...

Continue Reading